Agios Pharmaceuticals, Inc.
AGIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001439222
In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Agios Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 168 | 3 | 160 | −5 |
| Shares | 58.0M | 68.7K | 59.5M | +1.56M (+2.7%) |
| Value | $1.64B | $1.94M | $1.67B | +$31.9M (+2.0%) |
3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Agios Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 279,557 | $7.85M | 0.03% |
| Bank of Montreal | 122,855 | $3.50M | 0.00% |
| Parkman Healthcare Partners LLC | 50,000 | $1.40M | 0.37% |
| Qube Research & Technologies Ltd | 39,061 | $1.10M | 0.01% |
| Capula Management Ltd | 33,020 | $927.2K | 0.10% |
| Jane Street Group, LLC | 29,716 | $834.4K | 0.00% |
| Schonfeld Strategic Advisors LLC | 23,700 | $665.5K | 0.01% |
| Jump Financial, LLC | 20,895 | $586.7K | 0.03% |
| ExodusPoint Capital Management, LP | 14,025 | $394.0K | 0.01% |
| HRT Financial LP | 13,147 | $369.0K | 0.01% |
| Aigen Investment Management, LP | 9,814 | $275.6K | 0.04% |
| NinePointTwo Capital | 8,717 | $244.0K | 0.10% |
| Janus Henderson Group PLC | 8,589 | $241.1K | 0.00% |
| Caligan Partners LP | 4,333 | $121.7K | 0.10% |
| Advisory Services Network, LLC | 350 | $9.83K | 0.00% |
| Concord Wealth Partners | 200 | $5.62K | 0.00% |
| Steward Financial Group LLC | 5 | $0 | 0.00% |
Sold out (22)
Institutions that held Agios Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Integral Health Asset Management, LLC | 100,000 | $2.83M |
| Walleye Capital LLC | 85,629 | $2.42M |
| Millennium Management LLC | 58,421 | $1.65M |
| Cubist Systematic Strategies, LLC | 46,593 | $1.32M |
| Graham Capital Management, L.P. | 42,062 | $1.19M |
| Renaissance Technologies LLC | 31,000 | $877.0K |
| AlphaCrest Capital Management LLC | 26,458 | $748.0K |
| Simplex Trading, LLC | 15,807 | $447.0K |
| AlphaCentric Advisors LLC | 15,000 | $424.0K |
| Marshall Wace, LLP | 14,413 | $408.0K |
| Y-Intercept (Hong Kong) Ltd | 11,246 | $318.0K |
| SEI Investments Co | 10,847 | $307.0K |
| Quantamental Technologies LLC | 9,573 | $271.0K |
| Gsa Capital Partners LLP | 8,986 | $254.0K |
| Point72 Hong Kong Ltd | 5,978 | $169.0K |
| Walleye Trading LLC | 3,678 | $104.0K |
| Amundi | 3,264 | $95.0K |
| Lazard Asset Management LLC | 3,061 | $86.0K |
| Princeton Global Asset Management LLC | 29 | $1.00K |
| Quent Capital, LLC | 23 | $1.00K |
| Ellevest, Inc. | 8 | $0 |
| Parallel Advisors, LLC | 4 | $0 |
Not filed for Q4 2022 yet (3)
Institutions that held Agios Pharmaceuticals, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Eaton Vance Management | 68,447 | $1.94M |
| Wipfli Financial Advisors LLC, | 228 | $6.00K |
| American Portfolios Advisors | 45 | $1.27K |